Skip to content

Clinical trials

Medulloblastoma trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Medulloblastoma Country / region: Italy Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20111
20121
20131
20141
20161
20171
20201
20211
20222
20231
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated4
Active, not recruiting2
Not yet recruiting2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fondazione Policlinico Universitario Agostino Gemelli IRCCS3
Novartis Pharmaceuticals3
Bambino Gesù Hospital and Research Institute1
Bristol-Myers Squibb1
Celgene1
Centre Leon Berard1
Eli Lilly and Company1
European Organisation for Research and Treatment of Cancer - EORTC1
Hoffmann-La Roche1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Medulloblastoma15
Glioma9
Brain Neoplasms5
Neuroblastoma5
Recurrence5
Ependymoma4
Rhabdomyosarcoma4
Sarcoma, Ewing3
Central Nervous System Neoplasms2
Diffuse Intrinsic Pontine Glioma2

Trials

Showing 51 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.